These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 921442)

  • 21. [Renal scleroderma crisis. Role of scleroderma vasculopathy in the induction of cutaneous and visceral fibrosis in 2 cases].
    Cuchacovich M; Holuigue G; Gatica H; Alvo M; Murray G
    Rev Med Chil; 2000 Jan; 128(1):86-92. PubMed ID: 10883527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic significance of controlled and uncontrolled arterial hypertension in patients with terminal kidney failure on chronic hemodialysis].
    Milovanova LIu; Nikolaev AIu; Lifshits NL; Milovanov IuS
    Ter Arkh; 2002; 74(6):45-9. PubMed ID: 12136483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure, circulating renin and the body sodium/volume state in patients with mild renal failure.
    Beretta-Piccoli C; Weidmann P; de Chatel R; Reubi FC
    Proc Eur Dial Transplant Assoc; 1976; 12():291-8. PubMed ID: 935120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic and prognostic value of the separated renin in hypertension due to monolateral nephropathy].
    Pessina AC; Corgnati A; Dal Palù C
    Quad Sclavo Diagn; 1975 Jun; 11(2):257-65. PubMed ID: 1223937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of renal failure and control of hypertension in patients with occlusion of the renal artery.
    May J; Sheil AG; Horvath J; Tiller DJ; Johnson JR
    Surg Gynecol Obstet; 1976 Sep; 143(3):411-3. PubMed ID: 959962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The kidney in systemic scleroderma. A report of 38 consecutive cases ].
    François B; Moulin G; Assenat H; Jandot B; Cahen R
    Nephrologie; 1982; 3(2):85-91. PubMed ID: 7121705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
    Bras H; Ochs HG; Armbruster H; Heintz R
    Clin Nephrol; 1976 Feb; 5(2):57-60. PubMed ID: 943254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteinuria and nephrotic syndrome induced by renin in patients with renal artery stenosis.
    Kumar A; Shapiro AP
    Arch Intern Med; 1980 Dec; 140(12):1631-4. PubMed ID: 7006541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin-angiotensin system in normotensive and hypertensive patients with progressive systemic sclerosis: hyporesponsiveness of renin during captopril test.
    Guillevin L; Leenhardt A; Godeau P
    Postgrad Med J; 1983; 59 Suppl 3():171-2. PubMed ID: 6359107
    [No Abstract]   [Full Text] [Related]  

  • 32. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders].
    Ermolenko VM; Lifshits NL; Zisel'man SB; Tatsievskiĭ VA
    Urol Nefrol (Mosk); 1991; (3):41-8. PubMed ID: 1871923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.
    Traub YM; Shapiro AP; Rodnan GP; Medsger TA; McDonald RH; Steen VD; Osial TA; Tolchin SF
    Medicine (Baltimore); 1983 Nov; 62(6):335-52. PubMed ID: 6355755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Importance of the longterm follow up of plasma renin activity in relation to arterial hypertension in chronic renal failure (author's transl)].
    Horký K; Dvoráková J; Lachmanová J; Tomásek R
    Sb Lek; 1978; 80(7-8):230-41. PubMed ID: 684361
    [No Abstract]   [Full Text] [Related]  

  • 36. Scleroderma kidney disease: a therapeutic approach with nephrectomy and hemodialysis.
    Cheigh JS; Kim SJ
    J Dial; 1977; 1(4):349-56. PubMed ID: 608857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The bilateral nephrectomy in terminal renal disease (author's transl)].
    Klosterhalfen H; Huland H; Augustin HJ; Burchardt P; Gonnermann D
    Urologe A; 1978 May; 17(3):155-9. PubMed ID: 653907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predicting development of renal involvement in progressive systemic sclerosis.
    Steen VD; Medsger TA; Osial TA; Ziegler GL; Shapiro AP; Rodnan GP
    Am J Med; 1984 May; 76(5):779-86. PubMed ID: 6372452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kidney in progressive systemic sclerosis: a prospective study.
    Kovalchik MT; Guggenheim SJ; Silverman MH; Robertson JS; Steigerwald JC
    Ann Intern Med; 1978 Dec; 89(6):881-7. PubMed ID: 717985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolution of renal failure with malignant hypertension in scleroderma. Case report and review of the literature.
    Simon NM; Graham MB; Kyser FA; Gashti EN
    Am J Med; 1979 Sep; 67(3):533-9. PubMed ID: 474603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.